In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
New survey finds that workers want pharmacy benefits that are modern, seamless, and supportive.
As the gene therapy market evolves, it’s more important than ever for employers to put the right gene therapy management program in place.
Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.
Investment Further Enhances Evernorth’s Participation in Growing Market for Specialty Medicine
Meet Kenya, an Accredo patient who is living with multiple sclerosis (MS). Watch the video to learn more about her journey of managing her condition with the support of Accredo Specialty Pharmacy.
Acquisition expands Evernorth’s capabilities to lower the cost of care – while increasing access to health care providers – through virtual visits